JonathanZhengLiMD
Infectious Disease • Boston, MAAssociate Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School
Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# PBB-A4
Boston, MA 02115Phone+1 617-768-8476
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2007 - 2009
University of California (San Francisco)Residency, Internal Medicine, 2004 - 2007- University of California San Francisco School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2006 - Present
MA State Medical License 2008 - 2025
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treat...Mark J Giganti, Kara W Chew, Carlee Moser, Joseph J Eron, Mauricio Pinilla
Contemporary Clinical Trials. 2025-03-25 - Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies.Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, Judith S Currier, Joseph J Eron
Iscience. 2025-03-21 - Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.Tin Phan, Ruy M Ribeiro, Gregory E Edelstein, Julie Boucau, Rockib Uddin
Journal of Virology. 2025-03-18
Journal Articles
- The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Post-Treatment Controllers Identified from 14 Clinical StudiesElizabeth Connick, Michael C Sneller, Jonathan Z Li, Paul Volberding, Daniel R Kuritzkes, Robert T Schooley, David Margolis, Daniel Skiest, John W Mellors, Ronald Mits..., The Journal of Infectious Diseases
- HIV-1 Latent Reservoir Size and Diversity Are Stable Following Brief Treatment InterruptionRobert F. Siliciano, Jonathan Z. Li, Katharine J. Bar, James Hoxie, Pablo Tebas, The Journal of Clinical Investigation
Press Mentions
Types of HIV Papers — A Quick GuideMay 15th, 2023- For Some COVID Patients, ‘Paxlovid Rebound’ Has Nothing to Do with PaxlovidNovember 14th, 2022
- High Nasal and Total SARS-CoV-2 RNA Levels Associated with Longer RecoveryNovember 9th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
